NGM Biopharmaceuticals (NGM)

Earnings in 2023 (TTM): -€0.14 Billion

According to NGM Biopharmaceuticals's latest financial reports the company's current earnings are €4.41 Million. In 2022 the company made an earning of -€0.14 Billion a decrease over its 2021 earnings that were of -€0.11 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for NGM Biopharmaceuticals from 2018 to 2023

Annual earnings

Year	Earnings	Change
2023 (TTM)	-€0.14 Billion	-5.35%
2022	-€0.14 Billion	35.18%
2021	-€0.11 Billion	17.41%
2020	-€87.31 Million	139.48%
2019	-€36.46 Million	8580.53%
2018	-€0.42 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Onconova Therapeutics ONTX	-€15.47 Million	-87.25%	🇺🇸 USA
OPKO Health OPK	-€0.14 Billion	12.01%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for NGM Biopharmaceuticals (NGM)

Earnings in 2023 (TTM): -€0.14 Billion